PMS-EMTRICITABINE-TENOFOVIR

Pharmascience Inc🇨🇦 Health Canada

Approval Id: fffffd8819e8e707
Drug Approval Canada Name: PMS-EMTRICITABINE-TENOFOVIR
Product Name: PMS-EMTRICITABINE-TENOFOVIR
Status: Marketed
Status Date: 2019-09-12
Original Market Date: 2019-09-12
Din: 02461110
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 08:18.08.20
Atc Original: J05AR03 TENOFOVIR DISOPROXIL AND EMTRICITABINE
Atc Name: j 05 ar 03
Aig Number: 0251568001
Company Name: Pharmascience Inc
Company Address: 100, 6111 Royalmount Ave, Montreal, Quebec, Canada, H4P 2T4
Company Detail Path: /organization/pharmascience-inc

EMTRICITABINE

200 MG

TENOFOVIR DISOPROXIL FUMARATE

300 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

fffffd8819e8e707

Type

Standard